Primary Mold-Active Antifungal Prophylaxis Decreases the Need for Chest Computed Tomography Scans in Patients with Acute Lymphoblastic Leukemia

Siopi, M. Karakatsanis S, Roumpakis C, Korantanis K, Sambatakou H, Sipsas NV, Tsirigotis P, Pagoni M, Meletiadis J (2021) A Prospective multicenter cohort surveillance study of ınvasive aspergillosis in patients with hematologic malignancies in Greece: Impact of the Revised EORTC/MSGERC 2020 Criteria. J Fungi (Basel) 7(1). Epub 2021 Jan 5. Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA (2018) Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect 24(Suppl 1):e1–e38 (Epub 2018 May 01) Lass-Flörl C (2019) How to make a fast diagnosis in invasive aspergillosis. Med Mycol 57:S155–S160 Groll AH, Castagnola E, Cesaro S, Dalle JH, Engelhard D, Hope W, Roilides E, Styczynski J, Warris A, Lehrnbecher T (2014) Fourth European Conference on infections in Leukemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haematopoietic stem cell transplantation. Lancet Oncol 15:e327–e340. Mellinghoff SC, Panse J, Alakel N, Behre G, Buchheidt D, Christopeit M, Hasenkamp J, Kehl M, Koldehoff M, Krause SW, Lehners N, Lilienfeld-Toall MV, Löhnert AY, Maschmeyer G, Teschner D, Ullmann AJ, Penack O, Ruhnke M, Mayer K, Ostermann H, Wolf HH, Cornely OA (2018) Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Ann Hematol 97:197–207 Lehrnbecher T, Fisher BT, Phillips B, Beauchemin M, Carlesse F, Castagnola E, Duong N, L Dupuis L, Fioravantti V, Groll AH, Haeusler GM, Roilides E, Science M, Steinbach WJ, Tissing W, Warris A, Patel P , Robinson PD, Sung Ll (2020) Clinical practice guideline for systemic antifungal prophylaxis in pediatric patients with cancer and hematopoietic stem-cell transplantation recipients. J Clin Oncol 38:3205–3216. Tissot F, Agrawal S, Pagano L, Petrikkos G, Groll AH, Skiada A, LASS Fröll c, Calandra T, Viscoli C, Herbrecht R (2017) ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica 102:433–444. Warris A, Lehrnbecher T, Roilides E, Castagnola E, Brüggemann RJM, Groll AH (2019) ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children. Clin Microbiol Infect 25:1096–1113 Ferreras- Antolin L, Sharland M, Warris A (2019) Management of invasive fungal disease in neonates and children. Pediatr Infect Dis J 38:S2–S6 Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA, Beauchemin M, Carlesse F, Groll AH, Haeusler GM, Santolaya M, Steinbach WJ, Castagnola E, Davis BL, Dupuis LL, Gaur AH, Tissing WJE, Zaoutis T, Phillips R, Sung L (2017) Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem cell transplantation recipients: 2017 update. J Clin Oncol 18:2082–2094 Krille L, Dreger S, Schindel R, Albrecht T, Asmussen M (2015) Risk of cancer incidence before the age of 15 years after exposure to ionizing radiation from computed tomography: results from a German cohort study. Radiation Environ Biophys 54:1–12 Miglioretti DL, Johnson E, Williams A, Greenlee RT, Weinmann S, Solberg LI, Feigelson HS, Roblin D, Flynn MJ, Vanneman N, Rebecca S-B (2013) Pediatric computed tomography and associated radiation exposure and estimated cancer risk. JAMA Pediatr 167:700–707 Mathews JD, Forsythe AV, Brady Z, Butler MW, Goergen SK, Byrnes GB, Giles GG, Wallace AB, Anderson PR, Guiver TA, McGale P, Cain TM, Dowty JG, Adrian Bickerstaffe C, Darby SC (2013) Cancer risk in 680 000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ 346:f2360 Meulepas JM, Ronckers CM, Smets AMJB, Nievelstein RAJ, Lee C, Kieft M, Lameris JS, Herk MV, Greuter MJW, Jeukens CRLPN, Straten MV, Visser O, Leeuwen FEV, Hauptmann M (2014) Leukemia and brain tumors among children after radiation exposure from CT scans: design and methodological opportunities of the Dutch Pediatric CT Study. Eur J Epidemiol 29:293–301. Rieger C, Herzog P, Eibel R, Fiegl M, Ostermann H (2008) Pulmonary MRI—a new approach for the evaluation of febrile neutropenic patients with malignancies. Support Care Cancer 16:599–606 Attenberger UI, Morelli JN, Henzler T, Buchheidt D, Fink C, Schoenberg SO, Reichert M (2014) 3 Tesla proton MRI for the diagnosis of pneumonia/lung infiltrates in neutropenic patients with acute myeloid leukemia: Initial results in comparison to HRCT. Eur J Radiol 83:e61–e66 Journy N, Ancelet S, Rehel JL, Mezzarobba M, Aubert B, Laurier D, Bernier MO (2014) Predicted cancer risks induced by computed tomography examinations during childhood, by a quantitative risk assessment approach. Radiat Environ Biophys 53:39–54 Pana ZD, Kourti M, Vikelouda A, Katzilakis N, Papageorgiou M, Doganis D, Petrikkos L, Paisiou A, Koliouskas D, Kattamis A, Stiakaki E, Chatzistilianou M, Vasilatou-Kosmidis H, Polychronopoulou S, Grafakos S, Roilides E (2018) Voriconazole antifungal prophylaxis in children with malignancies: a nationwide study. J Pediatr Hematol Oncol 40:22–26 Tragiannidis A, Dokos C, Lehrnbecher T, Groll AH (2012) Antifungal chemoprophylaxis in children and adolescents with haematological malignancies and following allogeneic haematopoietic stem cell transplantation: review of the literature and options for clinical practice. Drugs 72:685–704 Meryk A, Kropshofer G, Hutter J, Fritz J, Salvador C, Lass-Flörl C, Crazzolara R (2020) Benefits of risk-adapted and mould-specific antifungal prophylaxis in childhood leukemia. Br J Haematol 191:816–824 Fisher BT, Kavcic M, Li Y, Seif AE, Bagatell R, Huang YS, Zaoutis T, Torp K, Leckerman KH, Aplenc R (2014) Antifungal prophylaxis associated with decreased induction mortality rates and resources utilized in children with new onset acute myeloblastic leukemia. Clin Infect Dis 58(4):502–508. Epub 2013 Nov 23. Kobayashi R, Hori D, Sano H, Suzuki D, Kishimoto K, Kobayashi K (2018) Risk factors for invasive fungal infection in children and adolescents with hematologic and malignant diseases: a 10-year analysis in a single institute in Japan. Pediatr Infect Dis J 37:1282–1285 Pauw BD, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821 Sahbudak Bal Z, Yilmaz Karapinar D, Karadas N, Sen S, Onder Sivis Z, Akinci AB, Balkan C, Kavakli K, Vardar F, Aydinok Y (2015) Proven and probable invasive fungal infections in children with acute lymphoblastic leukemia: results from an university hospital, 2005–2013. Mycoses 58:225–232 Sathya C, Alali AS, Wales PW, Langer JC, Kenney BD, Burd RS, Nance ML, Nathens AB (2019) Computed tomography rates and estimated radiation-associated cancer risk among injured children treated at different trauma center types. Injury Int J Care Injured 50:142–148 Berrington de G, Kim KP, Samet JM (2007) Radiation-induced cancer risk from annual computed tomography for patients with cystic fibrosis. Am J Respir Crit Care 179:970–973. Boice JD (2015) Radiation epidemiology and recent paediatric computed tomography studies. Ann ICRP 44:236–248 Chodick G, Ronckers CM, Shalev V, Ron E (2007) Excess lifetime cancer mortality risk attributable to radiation exposure from computed tomography examinations in children. IMAJ 9:584–587 Mathews J.D., Forsythe A.V., Brady Z., Butler MV, Georgen SV et al (2013) Cancer risk in 680 000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ, 346. https://doi.org/10.1136/bmj.f2360 ). Kuhns LR, Oliver VJ Christodoulou E, Goodsitt MM (2011) The predicted increased cancer risk associated with a single computed tomography examination for calculus detection in pediatric patients compared with the natural cancer incidence. Pediatr Emerg Care 27(4):345–350. https://doi.org/10.1097/PEC.0b013e3182132016 Chodick G, Ronckers GM,Shalev V, Ron E (2007) Excess lifetime cancer mortality risk attritutable to radiation exposure from computed tomography examinations in children. IMAJ, pp 584–587. Brenner DJ (2002) Estimating cancer risks from pediatric CT:going from the qualitative to the quantitative. Pediatr Radiol 32:228–231